JOIN THE BNMS             

               XLargeThumb.00006231-201401000-00000.CV

Twitter @BNMSnews

INCAPS-The International Atomic Energy Agency (IAEA) Nuclear Cardiology Protocol Survey Study - Invitation to Participate

The BNMS in association with the BNCS would encourage participation in this important survey of Nuclear Cardiology practice.

Dear Colleague,

We're contacting you in regards to a very important survey of the nuclear cardiology community being performed under the auspices of the International Atomic Energy Agency (I.A.E.A.) in Vienna.

xlsDownload Survey Here

Thank you very much for considering participating in the survey.

As you are well aware, the way in which nuclear cardiology is being performed around the world is continually evolving and we are often guided in our practice by not only evidence-based medicine, but by what our colleagues are doing.

This very simple survey is trying to evaluate what each nuclear cardiology practice around the world is doing in terms of tracer utilisation, doses used and technology that is available. This is not a test of your practice. We are simply trying to find out what each centre is doing in 2013, so that further information can be gathered that potentially could help all of our practices in the future.

The attached survey is self-explanatory, and requires the filling in of anonymised data for one week of your nuclear cardiology patients in the attached spreadsheet, which is in Microsoft Excel format. No patient-identifiable information will be collected. You can choose any single week between the week beginning March 18 and the week beginning May 13, inclusive.

The data is extremely easy to enter and has been designed so that it can be filled in according to your local preference (either kg or lbs and mCi or MBq).
Of note to U.S. laboratories, this survey collects no protected health information/individually identifiable health information, as defined in 45 CFR §164.514(b). As such, it has been deemed by the Columbia University Institutional Review Board that this study is exempt from HIPAA requirements and does not constitute Human Subjects Research in accordance with its definition in 45 CFR §46.102(f).

If you have any questions or comments, the organizing committee would be very happy to hear from you and assist you in any way possible. You are welcome to email us at  INCAPS@iaea.org. Please email completed surveys to this same email address.

Only a single spreadsheet received from each laboratory can be included in our survey. If multiple individuals from your laboratory have received this invitation, please decide on one individual to respond. Of note to our colleagues in Australia, New Zealand, and Europe, you may have received this request either directly from IAEA, from your professional society (AANMS or EANM), or from both.

Regardless of how you received the invitation, we request only one response per laboratory.

If you have any colleagues from other laboratories who practice nuclear cardiology but have not received this invitation, please forward us their contact information and we will be glad to invite them.
We are very conscious that this survey can take up your time and limited resources, and we are most appreciative of your assistance with what may well prove to be very important data collection. One individual for each laboratory can be designated as the primary investigator for the laboratory. Primary investigators will be included and listed as members of the INCAPS Investigators Group, which will author publications from the data collected in INCAPS.

In addition, thanks to grant funding provided by the Margaret Q. Landenberger Foundation, a US-based philanthropy, the PI for the first five laboratories responding in each US state and Canadian province, and, where permitted by law, the first 150 laboratories responding from other IAEA member states, will receive US$100 to compensate them for time and effort involved. This compensation is in addition to your inclusion as a co-author in the INCAPS Investigators Group.

Thanking you in advance.

With kindest regards,

Drs Maurizio Dondi, Thomas NB Pascual and Andrew Einstein (On behalf of the organising committee of INCAPS)

Section of Nuclear Medicine and Diagnostic Imaging, Division of Human Health, Department of Nuclear Sciences and Applications | International Atomic Energy Agency | Vienna International Centre, PO Box 100, 1400 Vienna, Austria |